Extensive crosstalk between O-GlcNAcylation and phosphorylation regulates Akt signaling

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Wang, Shuai ^a   Huang, Xun ^a   Sun, Danni ^a   Xin, Xianliang ^a   Pan, Qiuming ^a   Peng, Shuying ^a   Liang, Zhongjie ^a   Luo, Cheng ^a   Yang, Yiming ^a   Jiang, Hualiang ^a   Huang, Min ^a   Chai, Wengang ^a,b   Ding, Jian ^a   Geng, Meiyu ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

N ACETYLGLUCOSAMINE; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEIN KINASE B;

ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; MASS SPECTROMETRY; MUTAGENESIS; PROTEIN GLYCOSYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

CELL LINE; CELLS, CULTURED; GLYCOSYLATION; HUMANS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 84861306218     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037427     Document Type: Article

References (47)

1. Jones PF, Jakubowicz T, Pitossi FJ, Maurer F, Hemmings BA, (1991) Molecular cloning and identification of a serine/threonine protein kinase of the second-messenger subfamily. Proc Natl Acad Sci U S A 88: 4171-4175.
2. Manning BD, Cantley LC, (2007) AKT/PKB signaling: navigating downstream. Cell 129: 1261-1274.
3. Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB, (2005) Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov 4: 988-1004.
4. DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB, (2008) The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 7: 11-20.
5. Yang WL, Wu CY, Wu J, Lin HK, (2010) Regulation of Akt signaling activation by ubiquitination. Cell Cycle 9: 487-497.
6. Yang XJ, (2005) Multisite protein modification and intramolecular signaling. Oncogene 24: 1653-1662.
7. Sims RJ 3rd, Reinberg D, (2008) Is there a code embedded in proteins that is based on post-translational modifications? Nat Rev Mol Cell Biol 9: 815-820.
8. Alessi DR, Andjelkovic M, Caudwell FB, Cron P, Morrice N, et al. (1996) Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J 15: 6541-6551.
9. Walker KS, Deak M, Paterson A, Hudson K, Cohen P, et al. (1998) Aberrant O-GlcNAcylation characterizes chronic lymphocytic leukemia. Biochem J 331: 299-308.
10. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM, (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307: 1098-1101.
11. Millward TA, Zolnierowicz S, Hemmings BA, (1999) Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem Sci 24: 186-191.
12. Arroyo JD, Hahn WC, (2005) Involvement of PP2A in viral and cellular transformation. Oncogene 24: 7746-7755.
13. Brognard J, Sierecki E, Gao T, Newton AC, (2007) PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms. Mol Cell 25: 917-931.
14. Yang WL, Wang J, Chan CH, Lee SW, Campos AD, et al. (2009) The E3 ligase TRAF6 regulates Akt ubiquitination and activation. Science 325: 1134-1138.
15. Suizu F, Hiramuki Y, Okumura F, Matsuda M, Okumura AJ, et al. (2009) The E3 ligase TTC3 facilitates ubiquitination and degradation of phosphorylated Akt. Dev Cell 17: 800-810.
16. Hart GW, Housley MP, Slawson C, (2007) Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins. Nature 446: 1017-1022.
17. Love DC, Hanover JA, (2005) The hexosamine signaling pathway: deciphering the "O-GlcNAc code". Sci. STKE 312, re13.
18. Shi Y, Tomic J, Wen F, Shaha S, Bahlo A, et al. (2010) Aberrant O-GlcNAcylation characterizes chronic lymphocytic leukemia. Leukemia 24: 1588-1598.
19. Vosseller K, Wells L, Lane MD, Hart GW, (2002) Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes. Proc Natl Acad Sci U S A 99: 5313-5318.
20. Yang X, Ongusaha PP, Miles PD, Havstad JC, Zhang F, et al. (2008) Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance. Nature 451: 964-969.
21. Macauley MS, Bubb AK, Martinez-Fleites C, Davies GJ, Vocadlo DJ, (2008) Elevation of global O-GlcNAc levels in 3T3-L1 adipocytes by selective inhibition of O-GlcNAcase does not induce insulin resistance. J Biol Chem 283: 34687-34695.
22. Macauley MS, He Y, Gloster TM, Stubbs KA, Davies GJ, et al. (2010) Inhibition of O-GlcNAcase using a potent and cell-permeable inhibitor does not induce insulin resistance in 3T3-L1 adipocytes. Chem Biol 17: 937-948.
23. Soesanto YA, Luo B, Jones D, Taylor R, Gabrielsen JS, et al. (2008) Regulation of Akt signaling by O-GlcNAc in euglycemia. Am J Physiol Endocrinol Metab 295: E974-80.
24. Kang ES, Han D, Park J, Kwak TK, Oh MA, et al. (2008) O-GlcNAc modulation at Akt1 Ser473 correlates with apoptosis of murine pancreatic beta cells. Exp Cell Res 314: 2238-2248.
25. Gandy JC, Rountree AE, Bijur GN, (2006) Akt1 is dynamically modified with O-GlcNAc following treatments with PUGNAc and insulin-like growth factor-1. FEBS Lett 580: 3051-3058.
26. Matthews JA, Belof JL, Acevedo-Duncan M, Potter RL, (2007) Glucosamine-induced increase in Akt phosphorylation corresponds to increased endoplasmic reticulum stress in astroglial cells. Mol Cell Biochem 298: 109-123.
27. Slawson C, Zachara NE, Vosseller K, Cheung WD, Lane MD, et al. (2005) Perturbations in O-linked beta-N-acetylglucosamine protein modification cause severe defects in mitotic progression and cytokinesis. J Biol Chem 280: 32944-32956.
28. Wang Z, Gucek M, Hart GW, (2008) Cross-talk between GlcNAcylation and phosphorylation: site-specific phosphorylation dynamics in response to globally elevated O-GlcNAc. Proc Natl Acad Sci U S A 105: 13793-13798.
29. Wang Z, Udeshi, ND, Slawson C, Compton PD, Sakabe K, et al. (2010) Extensive crosstalk between O-GlcNAcylation and phosphorylation regulates cytokinesis. Sci Signal 3(104), ra2.
30. Chalkley RJ, Wells L, Vosseller K, (2009) Comprehensive Analytical Chemistry, Volume 52. O-GlcNAc Proteomics Mass Spectrometric Analysis of O-GlcNAc Modifications on Proteins, Whitelegge JP (ed) 353-374. Elsevier B.
31. Kohler JJ, (2010) Post-translational modifications: A shift for the O-GlcNAc paradigm. Nat Chem Bio. 6: 634-635.
32. Rexach JE, Rogers CJ, Yu SH, Tao J, Sun YE, et al. (2010) Quantification of O-glycosylation stoichiometry and dynamics using resolvable mass tags. Nat Chem Biol 6: 645-651.
33. Ball LE, Berkaw MN, Buse MG, (2006) Identification of the major site of O-linked beta-N-acetylglucosamine modification in the C terminus of insulin receptor substrate-1. Mol Cell Proteomics 5: 313-323.
34. Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, et al. (2006) Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 127: 635-648.
35. Dephoure N, Zhou C, Villen J, Beausoleil SA, Bakalarski CE, et al. (2008) A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci U S A 105: 10762-10767.
36. Lippa B, Pan G, Corbett M, Li C, Kauffman GS, et al. (2008) Synthesis and structure based optimization of novel Akt inhibitors. Bioorg Med Chem Lett 18: 3359-3363.
37. Jo M, Thomas KS, O'Donnell DM, Gonias SL, (2003) Epidermal growth factor receptor-dependent and-independent cell-signaling pathways originating from the urokinase receptor. J Biol Chem 278: 1642-1646.
38. Yang XJ, Seto E, (2008) Lysine acetylation: codified crosstalk with other posttranslational modifications. Mol Cell 31: 449-461.
39. Hunter T, (2007) The age of crosstalk: phosphorylation, ubiquitination, and beyond. Mol Cell 28: 730-738.
40. Carr SM, Munro S, Kessler B, Oppermann U, La Thangue NB, (2011) Interplay between lysine methylation and Cdk phosphorylation in growth control by the retinoblastoma protein. EMBO J 30: 317-327.
41. Yang WH, Kim JE, Nam HW, Ju JW, Kim HS, et al. (2006) Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability. Nat Cell Biol 8: 1074-1083.
42. Park SY, Kim HS, Kim NH, Ji S, Cha SY, et al. (2010) Snail1 is stabilized by O-GlcNAc modification in hyperglycaemic condition. EMBO J 29: 3787-3796.
43. Zachara NE, Hart GW, (2002) The emerging significance of O-GlcNAc in cellular regulation. Chem Rev 102: 431-438.
44. Klein A, Berkaw MN, Buse MG, Ball LE, (2009) O-linked N-acetylglucosamine modification of insulin receptor substrate-1 occurs in close proximity to multiple SH2 domain binding motifs. Mol Cell Proteomics 8: 2733-2745.
45. Schneider C, Newman RA, Sutherland DR, Asser U, Greaves MF, (1982) A one-step purification of membrane proteins using a high efficiency immunomatrix. J Biol Chem 257: 10766-10769.
46. Mann M, Wilm M, (1994) Error-tolerant identification of peptides in sequence databases by peptide sequence tags. Anal Chem 66: 4390-4399.
47. Joost HG, Schürmann A, (2001) Subcellular fractionation of adipocytes and 3T3-L1 cells. Methods Mol Biol 155: 77-82.